Health & ScienceBiotechnology
China Approves World's First CAR-T Therapy for Solid Tumors
China's NMPA approved satri-cel, the world's first CAR-T therapy for solid tumors, targeting advanced gastric cancer at 990,000 yuan per infusion.
—5 min read
Category
1 article
China's NMPA approved satri-cel, the world's first CAR-T therapy for solid tumors, targeting advanced gastric cancer at 990,000 yuan per infusion.